Increased mucosal thrombin is associated with Crohn's disease and causes inflammatory damage through Protease-Activated Receptors activation

Archive ouverte

Motta, Jean-Paul | Palese, Simone | Giorgio, Carmine | Chapman, Kevin | Denadai-Souza, Alexandre | Rousset, Perrine | Sagnat, David | Guiraud, Laura | Edir, Anissa | Seguy, Carine | Alric, Laurent | Bonnet, Delphine | Bournet, Barbara | Buscail, Louis | Gilletta, Cyrielle | Buret, Andre | Wallace, John | Hollenberg, Morley | Oswald, Eric | Barocelli, Elisabetta | Le Grand, Sylvie | Le Grand, Bruno | Deraison, Céline | Vergnolle, Nathalie

Edité par CCSD ; Elsevier - Oxford University Press -

International audience. Background and Aims: Thrombin levels in the colon of Crohn’s disease patients have recently been found to be elevated 100-fold compared to healthy controls. Our aim was to determine whether and how dysregulated thrombin activity could contribute to local tissue malfunctions associated with Crohn’s disease.Methods: Thrombin activity was studied in tissues from Crohn’s disease patients and healthy controls. Intracolonic administration of thrombin to wild-type or protease-activated receptor-deficient mice was used to assess the effects and mechanisms of local thrombin upregulation. Colitis was induced in rats and mice by the intracolonic administration of trinitrobenzene sulfonic acid. Results: Active forms of thrombin were increased in Crohn's disease patient tissues. Elevated thrombin expression and activity were associated with intestinal epithelial cells. Increased thrombin activity and expression were also a feature of experimental colitis in rats. Colonic exposure to doses of active thrombin comparable to what is found in inflammatory bowel disease tissues caused mucosal damage and tissue dysfunctions in mice, through a mechanism involving both Protease-Activated Receptors-1 and -4. Intracolonic administration of the thrombin inhibitor Dabigatran, as well as inhibition of protease-activated receptor-1, prevented trinitrobenzene sulfonic acid-induced colitis in rodent models.Conclusions: Our data demonstrated that increased local thrombin activity, as it occurs in the colon of patients with inflammatory bowel disease, causes mucosal damage and inflammation. Colonic thrombin and protease-activated receptor-1 appear as possible mechanisms involved in mucosal damage and loss of function and therefore represent potential therapeutic targets for treating inflammatory bowel disease.

Suggestions

Du même auteur

Compte rendu de lecture : Sylvie Toscer-Angot, La reconnaissance de l’islam dans le système éducatif allemand des années 1980 à 2015, préface de Jean-Paul Willaime, Aix en Provence, Presses Universitaires d’Aix-Marseille (collection Droit et Religions), 2021, 228 p.

Archive ouverte | Le Grand, Sylvie | CCSD

International audience

Active thrombin produced by the intestinal epithelium controls mucosal biofilms

Archive ouverte | Motta, Jean-Paul | CCSD

International audience. Proteolytic homeostasis is important at mucosal surfaces, but its actors and their precise role in physiology are poorly understood. Here we report that healthy human and mouse colon epitheli...

Epithelial production of elastase is increased in inflammatory bowel disease and causes mucosal inflammation

Archive ouverte | Motta, Jean-Paul | CCSD

International audience. Imbalance between proteases and their inhibitors plays a crucial role in the development of Inflammatory Bowel Diseases (IBD). Increased elastolytic activity is observed in the colon of patie...

Chargement des enrichissements...